We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TTI market cap is 26.3M. The company's latest EPS is CAD -0.1129 and P/E is -1.95.
Year End December 30 2023 | 2021 | 2021 | 2022 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | 0 | -1.39M | -3k | -3.61M | -4.72M |
Net Income | -93k | -1.22M | -224k | -3.92M | -5.03M |
Year End December 30 2023 | 2021 | 2021 | 2022 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 146k | 231k | 3.43M | 6.29M | 7.24M |
Total Liabilities | 63k | 1.29M | 3.49M | 307k | 1.71M |
Total Equity | 83k | -1.06M | -61k | 5.98M | 5.53M |
Year End December 30 2023 | 2021 | 2021 | 2022 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -36k | -768k | -67k | -2.09M | -3.25M |
Investing | N/A | N/A | N/A | 107k | N/A |
Financing | N/A | 819k | 3.33M | 8.13M | 4.12M |
Market Cap | 26.3M |
Price to Earnings Ratio | -1.95 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.39 |
Price to Book Ratio | 1.77 |
Dividend Yield | - |
Shares Outstanding | 44.57M |
Average Volume (1 week) | 12.06k |
Average Volume (1 Month) | 17.92k |
52 Week Change | -19.18% |
52 Week High | 1.06 |
52 Week Low | 0.52 |
Spread (Intraday) | 0.06 (9.23%) |
Company Name | Thiogenesis Therapeutics Corp |
Address |
4 king street west, ste. 401 toronto, ontario M5H 1B6 |
Website | https://www.thiogenesis.com |
Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions